Articles Tagged With:
-
What Do Patients Know About Anti-Müllerian Hormone Testing?
In this randomized, controlled, online questionnaire trial, participants who received evidence-based information about anti-Müllerian hormone (AMH) testing had lower interest in getting an AMH test (mean difference, 1.05; 95% confidence interval, 0.83-1.30) than individuals who viewed the control information from a direct-to-consumer website.
-
Rethinking Endometrial Thickness Thresholds that Prompt Endometrial Biopsy to Rule Out Endometrial Cancer
In a retrospective review of 1,494 pre- and postmenopausal Black individuals who underwent transvaginal ultrasonography, 24 of 210 individuals (11.4%) with endometrial cancer had an endometrial thickness lower than the threshold for undergoing biopsy to detect cancer.
-
Reproductive Healthcare in Adolescents with Autism and Other Developmental Disabilities
This cohort study of 3,723 female adolescents from the Kaiser Permanente healthcare system in California found that adolescents with autism or developmental disability were less likely to see an OB/GYN or be prescribed contraception compared with their typically developing peers. This study identified disparities present in reproductive healthcare for this population, despite higher rates of menstrual-related diagnoses.
-
Emergencies in the First Week of Life
The first week of life is a critical period for newborns, marked by rapid physiological transitions and a heightened vulnerability to various medical emergencies. This article provides an in-depth exploration of several significant neonatal emergencies that can arise during this time.
-
Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic metabolic disease that you may never have heard of. MASLD, formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent liver disease worldwide. MASLD affects 30% of the world’s population, more than half of those people with obesity, and more than 70% of people with type 2 diabetes. While many clinicians may see patients with slightly elevated transaminases and assume it is fatty liver, MASLD is not benign and often begins well before laboratory changes. This article reviews the pathogenesis, diagnosis, and natural history of MASLD; known treatments; and future therapies.
-
Structural Racism Affects Family Planning and Needs Combatting, Study Says
Family planning has been linked with racism for centuries, and this legacy impact on 21st-century patients needs to be addressed in family planning research, a new paper says.
-
Strategies To Improve Contraceptive Counseling, Including for Prenatal Patients
Here are some strategies to improve contraceptive counseling for all patients, including those who are pregnant.
-
Perinatal Contraceptive Counseling Helps Patients Manage Reproductive Futures
Reproductive healthcare and contraceptive counseling have evolved in recent years to embrace patient-centered counseling and the reproductive justice framework. This focus should include the perinatal period, but that is not always the case, a new paper finds.
-
LARC Use Can Affect Well-Woman Visits and STI Screening
Adolescent and young adult patients who select long-acting reversible contraception (LARC) attend fewer well-woman visits and have reduced testing for sexually transmitted infections (STIs), new research shows.
-
Digital Contraceptive Decision Aid Has Potential to Help Match Patients to Best Option
Providers and patients who would like a little help in contraceptive counseling and decision-making could use a new tool — a digital contraceptive decision aid — that could enhance women’s confidence and satisfaction with their contraceptive recommendation, new research shows.